The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Transnational Institute this year after decades of work, has been at the forefront of these debates. In this interview, we discuss the WHO’s coca review, inter se treaty reform, and what these shifts mean for the future of global drug policy.

After 36 years of pioneering work in the field of harm reduction, Mainline, a leading Dutch harm reduction organisation, has to close due to budget constraints. We interviewed its executive director, Ancella Voets, on this occasion.

In this thought-provoking conversation, Prof. Dr. Thomas Metzinger, a leading philosopher of mind and consciousness, examines the profound potential — and serious risks — of psychedelics.

We interviewed Israeli psychotherapist Nir Tadmor about how he supported survivors of the Nova festival massacre and the deep emotional impact the tragedy had on the community.

In this interview, we talk with Erik Davis about the forgotten shadows of psychedelic history, the need for cultural memory, and the deeper meanings hidden within blotter art.

Creating supportive communities to integrate the psychedelic experience is just as important as ensuring a safe setting for the experience itself. Watch our interview with Rosalind Watts, a clinical psychologist and the founder of ACER Integration, UK!

Psychedelics are the master keys to unlocking hidden potentials in our brains, claims Gül Dölen, a Turkish-American neuroscientist and professor at UC Berkeley. Please watch and share Drugreporter’s interview, filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2024 in Haarlem, The Netherlands.

Janice Phelps is a clinical psychologist and she created the first academically accredited training program for the training of therapists in psychedelic-assisted psychotherapies.

We proudly present our videos filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) in June 2024, featuring many fascinating new research findings and incredible insights from world-renowned scientists and authors.

Drug Consumption Rooms are safe spaces where people can use drugs under hygienic conditions, with support, and without fear of violence or legal repercussions. Today, more than 140 legally-sanctioned DCRs operate in 11 European countries, as well as in Australia, Canada, Mexico and the USA. Join us on a global video tour to discover why they were established, how they support their local communities and how these life-saving harm reduction facilities have evolved over time.